Although heterozygous GPVs in five FA genes (BRCA1, BRCA2, PALB2, BRIP1, or RAD51C) confer high/moderate BC/OC risk, we found no association between FANCG GPVs and BC/OC risk. The gene discussed is RAD51C; the disease is breast cancer.